Dr Anna Singleton (she/her) is an NHMRC Emerging Leadership Fellow and Senior Research Fellow at the Daffodil Centre, with a background in psychology (PhD Dec 2021, MSc ExpPsych; BSc Hons I Psych). Anna leads a program of research that aims to improve access to health support and health outcomes of people living with and beyond cancer through inclusive co-design, digital health technologies, high-quality clinical trials, and implementation science. Anna’s team is passionate about working with people with/beyond cancer, clinicians, and non-profit orgs to find real-world solutions to big problems. Anna has been internationally recognised for her work, awarded the 2025 International Psychosocial Oncology Society’s Hiroomi and Setsuko Kawano New Investigator Award, top 25 Brilliant Woman in Digital Health in Australia by TelstraHeath (2022), 2023 NSW Premier’s Award for Outstanding Early Career Researcher and the Consumer Involvement Award at the Australian Clinical Trials Alliance Trial of the Year Awards. Anna has been awarded >$6M in research funds and awards (>$2.4M as CIA/B) and published >44 peer-reviewed manuscripts, including high-impact journals like the Journal of Clinical Oncology (IF 45.3).
View academic profile at sydney.edu.au
Twitter: @DrAnnaSingleton